Journal article
EV71 vaccine: protection from a previously neglected disease
The eagerly awaited results of a phase 3 trial of an inactivated enterovirus 71 (EV71) vaccine are reported by Feng-Cai Zhu and colleagues in The Lancet.1 EV71 is an important cause of hand, foot, and mouth disease (HFMD), but is also associated with more severe diseases in young children (aged ted HFMD and 80·4% (58·2—90·8) for EV71-associated disease (including herpangina, neurological complications, and non-specific illnesses caused by EV71). The vaccine had a satisfactory safety profile and the results are similar to those for inactivated poliovirus vaccine.
Authors
Languages
- English
Publication year
2013
Journal
The Lancet
Volume
9882
Type
Journal article
Categories
- Vaccines & delivery devices
Tags
- New vaccine introduction
